Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    July 2017
  1. TOMAO F, D'Incalci M, Biagioli E, Peccatori FA, et al
    Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30830.
    PubMed     Text format     Abstract available


  2. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    PubMed     Text format    


    June 2017
  3. BATEMAN NW, Dubil EA, Wang G, Hood BL, et al
    Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
    Cancer. 2017 Jun 27. doi: 10.1002/cncr.30813.
    PubMed     Text format     Abstract available


    May 2017
  4. KOROUKIAN SM, Bakaki PM, Htoo PT, Han X, et al
    The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30720.
    PubMed     Text format     Abstract available


  5. SCALICI JM, Arapovic S, Saks EJ, Atkins KA, et al
    Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
    Cancer. 2017;123:977-984.
    PubMed     Text format     Abstract available


  6. BALASUBRAMANIAM S, Kim GS, McKee AE, Pazdur R, et al
    Regulatory considerations on endpoints in ovarian cancer drug development.
    Cancer. 2017 May 12. doi: 10.1002/cncr.30652.
    PubMed     Text format     Abstract available


  7. IVY SP, Kohn EC
    Drug development and registration: Challenges and opportunities in ovarian cancer.
    Cancer. 2017 May 12. doi: 10.1002/cncr.30645.
    PubMed     Text format    


  8. HUANG GS, Santin AD
    Genetic landscape of clear cell endometrial cancer and the era of precision medicine.
    Cancer. 2017 May 9. doi: 10.1002/cncr.30743.
    PubMed     Text format    


  9. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
    Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Cancer. 2017 May 9. doi: 10.1002/cncr.30745.
    PubMed     Text format     Abstract available


  10. SMALL W JR, Bacon MA, Bajaj A, Chuang LT, et al
    Cervical cancer: A global health crisis.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30667.
    PubMed     Text format     Abstract available


  11. STOPECK AT
    Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?
    Cancer. 2017 May 2. doi: 10.1002/cncr.30678.
    PubMed     Text format    


  12. LIPTON A, Chapman JW, Leitzel K, Garg A, et al
    Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30682.
    PubMed     Text format     Abstract available


    April 2017
  13. BEN-AMI E, Barysauskas CM, Solomon S, Tahlil K, et al
    Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30738.
    PubMed     Text format     Abstract available


  14. PRINTZ C
    New treatment for patients with advanced ovarian cancer receives accelerated approval.
    Cancer. 2017;123:1286-1287.
    PubMed     Text format    


  15. ALSBEIH GA, Al-Harbi NM, Bin Judia SS, Khoja HA, et al
    Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Cancer. 2017 Apr 10. doi: 10.1002/cncr.30635.
    PubMed     Text format     Abstract available


  16. LIANG X, Margolis KL, Hendryx M, Reeves K, et al
    Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30688.
    PubMed     Text format     Abstract available


    March 2017
  17. QUINN AM, Minhajuddin AT, Hynan LS, Reisch JS, et al
    Agreement between cytotechnologists and cytopathologists as a new measure of cytopathologist performance in gynecologic cytology.
    Cancer. 2017 Mar 27. doi: 10.1002/cncy.21856.
    PubMed     Text format     Abstract available


  18. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


  19. STARK DP, Cook A, Brown JM, Brundage MD, et al
    Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.
    Cancer. 2017 Mar 24. doi: 10.1002/cncr.30657.
    PubMed     Text format     Abstract available


  20. SAMIMI G, Minasian LM
    Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
    PubMed     Text format    


    January 2017
  21. BRAR H, Hogen L, Covens A
    Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30509.
    PubMed     Text format     Abstract available


  22. BEAVIS AL, Gravitt PE, Rositch AF
    Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30507.
    PubMed     Text format     Abstract available


  23. DALTON HJ, Farley JH
    Racial disparities in cervical cancer: Worse than we thought.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30501.
    PubMed     Text format    


  24. TALHOUK A, McConechy MK, Leung S, Yang W, et al
    Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Cancer. 2017 Jan 6. doi: 10.1002/cncr.30496.
    PubMed     Text format     Abstract available


  25. MILLER DS
    Patients with endometrial cancer at risk for lymphatic metastasis should undergo pelvic and periaortic lymphadenectomy as part of their initial surgery.
    Cancer. 2017;123:192-196.
    PubMed     Text format    


  26. KANG S, Nam JH, Bae DS, Kim JW, et al
    Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study.
    Cancer. 2017;123:263-272.
    PubMed     Text format     Abstract available


  27. HURTEAU JA
    Omitting lymphadenectomy in patients with endometrial cancer.
    Cancer. 2017;123:197-199.
    PubMed     Text format    


    December 2016
  28. GREENWALD ZR, Huang LN, Wissing MD, Franco EL, et al
    Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30529.
    PubMed     Text format     Abstract available


  29. HOU JY, Baptiste C, Hombalegowda RB, Tergas AI, et al
    Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30473.
    PubMed     Text format     Abstract available


  30. WINDER AD, Maniar KP, Wei JJ, Liu D, et al
    Synuclein-gamma in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
    Cancer. 2016 Dec 7. doi: 10.1002/cncr.30477.
    PubMed     Text format     Abstract available


  31. OVESTAD IT, Dalen I, Hansen E, Loge JL, et al
    Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Cancer. 2016 Dec 5. doi: 10.1002/cncy.21807.
    PubMed     Text format     Abstract available


    November 2016
  32. GANESH K, Shah RH, Vakiani E, Nash GM, et al
    Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30424.
    PubMed     Text format     Abstract available


  33. FANG CY, Ma GX, Handorf EA, Feng Z, et al
    Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention.
    Cancer. 2016 Nov 21. doi: 10.1002/cncr.30391.
    PubMed     Text format     Abstract available


  34. RUNGRUANG BJ, Miller A, Krivak TC, Horowitz NS, et al
    What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
    Cancer. 2016 Nov 16. doi: 10.1002/cncr.30414.
    PubMed     Text format     Abstract available


    October 2016
  35. THOMPSON B, Carosso EA, Jhingan E, Wang L, et al
    Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30399.
    PubMed     Text format     Abstract available


  36. LI Y, Zeng J, Huang M, An J, et al
    A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Cancer. 2016 Oct 3. doi: 10.1002/cncr.30328.
    PubMed     Text format     Abstract available


    September 2016
  37. SILVER MI, Schiffman M, Fetterman B, Poitras NE, et al
    The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30277.
    PubMed     Text format     Abstract available


  38. HUH WK, Andrews JC
    Cervical cancer screening: How do we make sense of it all and what is the right balance?
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30276.
    PubMed     Text format    


  39. RAO P, Li Y, Getz KD, Miller TP, et al
    Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitals.
    Cancer. 2016 Sep 12. doi: 10.1002/cncr.30225.
    PubMed     Text format     Abstract available


  40. MAKKER V, Recio FO, Ma L, Matulonis UA, et al
    A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
    Cancer. 2016 Sep 7. doi: 10.1002/cncr.30286.
    PubMed     Text format     Abstract available


  41. MUTCH DG
    Targeted therapy in endometrial cancer: Making progress.
    Cancer. 2016 Sep 7. doi: 10.1002/cncr.30285.
    PubMed     Text format    


    August 2016
  42. RYDZEWSKI NR, Strohl AE, Donnelly ED, Kanis MJ, et al
    Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
    Cancer. 2016 Aug 10. doi: 10.1002/cncr.30228.
    PubMed     Text format     Abstract available


    July 2016
  43. DRESCHER CW, Beatty JD, Resta R, Andersen MR, et al
    The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.
    Cancer. 2016 Jul 22. doi: 10.1002/cncr.30190.
    PubMed     Text format     Abstract available


  44. DEL CARMEN MG, Supko JG, Horick NK, Rauh-Hain JA, et al
    Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30196.
    PubMed     Text format     Abstract available


    June 2016
  45. LEREBOURS F, Rivera S, Mouret-Reynier MA, Alran S, et al
    Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French t
    Cancer. 2016 Jun 17. doi: 10.1002/cncr.30143.
    PubMed     Text format     Abstract available


  46. MCALPINE JN, Temkin SM, Mackay HJ
    Endometrial cancer: Not your grandmother's cancer.
    Cancer. 2016 Jun 16. doi: 10.1002/cncr.30094.
    PubMed     Text format     Abstract available


  47. GEYER HL, Andreasson B, Kosiorek HE, Dueck AC, et al
    The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
    Cancer. 2016;122:1888-96.
    PubMed     Text format     Abstract available


  48. GUINDALINI RS, Song A, Fackenthal JD, Olopade OI, et al
    Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.
    Cancer. 2016;122:1913-20.
    PubMed     Text format     Abstract available


    May 2016
  49. WHOP LJ, Garvey G, Baade P, Cunningham J, et al
    The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
    Cancer. 2016;122:1560-9.
    PubMed     Text format     Abstract available


  50. LIAO ZW, Rodrigues MC, Poynter JN, Amatruda JF, et al
    Risk of second gonadal cancers in women and children with germ cell tumors.
    Cancer. 2016 May 6. doi: 10.1002/cncr.30014.
    PubMed     Text format     Abstract available


  51. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    April 2016
  52. PRINTZ C
    BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
    Cancer. 2016;122:1149.
    PubMed     Text format    


    March 2016
  53. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available


    February 2016
  54. ARMSTRONG K, Kim JJ, Halm EA, Ballard RM, et al
    Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Cancer. 2016 Feb 29. doi: 10.1002/cncr.29937.
    PubMed     Text format     Abstract available


    January 2016
  55. WALSH CS
    The more you look, the more you will find.
    Cancer. 2016;122:14-6.
    PubMed     Text format    


    October 2015
  56. HURTEAU JA, Febbraro T
    Germ cell tumors: Treatment consensus across all age groups through MaGIC [Malignant Germ Cell International Collaborative].
    Cancer. 2015 Oct 20. doi: 10.1002/cncr.29729.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: